Aquivia Health vs Vytora Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Aquivia Health
Best for Self-pay patients who want a clinician-reviewed (not algorithmic) compounded-GLP-1 pathway at the low end of the WLR compounded cluster ($149/mo semaglutide, $179/mo tirzepatide) AND want the option to upgrade to branded Ozempic/Zepbound at the same operator. Buyers who value a named clinical MSO partner (Open Loop Healthcare Partners, PC) and a co-founder team that publicly discloses credentials (MD + PharmD + operations executive). NOT ideal for buyers who require an upfront state-availability disclosure (Aquivia does not publish a state allowlist), buyers who require LegitScript/PCAB/BBB badges in the footer as a precondition (none visible in this verification pass), or buyers in coming-soon program categories (Performance Longevity, Dysautonomia/POTS are waitlist-only).Starting at $149/mo
Vytora Health
Best for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.Starting at $150/mo
Side-by-Side Comparison
| Feature | Aquivia Health | Vytora Health |
|---|---|---|
| Overall Score | 6.9/10 | ✓8.7/10 |
| Starting Price | ✓$149/mo | $150/mo |
| Editorial Rating | 3.5 ★ /5 | ✓4.4 ★ /5 |
| Features | 10 features | 10 features |
| States Available | 0 | ✓51 |
| Compounded | — | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | 4 warnings | ✓None |
Pros & Cons
Aquivia Health
Pros
- ✓Named clinical partner disclosed verbatim in site footer: 'Clinical care services provided by our partner clinicians at Open Loop Healthcare Partners, PC: openloophealth.com' — same MSO network used by several other DTC GLP-1 brands, which is a reused-and-verified trust signal
- ✓Named leadership team with credentials disclosed: Steven Bishop MD (CMO, Internal Medicine), Phillip Gray PharmD (Chief Pharmacist, 503A/USP background), Tom Foster (President)
- ✓Itemized pricing displayed publicly on /pricing and /programs/glp-1-weight-loss — Compounded Semaglutide $149/mo, Compounded Tirzepatide $179/mo, Ozempic $1,299/shipment, Zepbound $1,399/shipment
- ✓Both compounded AND branded GLP-1 options offered side-by-side, which is unusual — most DTC compounded providers do not also carry branded Ozempic/Zepbound
- ✓Self-pay model with no insurance required and no separate consultation fee (consult bundled into the monthly product price)
- ✓Multi-month prepay discounts disclosed publicly ('save $910 vs billed every 4 weeks' on 52-week semaglutide and tirzepatide tiers)
- ✓Explicit no-guarantee disclaimer ('Completing the check does not guarantee a prescription') is a positive clinical-safety signal vs platforms that imply guaranteed prescriptions
- ✓Multi-program platform with metabolic, longevity, and dysautonomia pathways (latter two waitlist-only) suggests a broader clinical scope than single-vertical compounded shops
Cons
- ✗No public state-availability allowlist — marketing copy says 'Nationwide distribution *where allowed by state law' but the FAQ acknowledges 'Not all therapies are available in every state' without disclosing which states are excluded; buyer must complete the eligibility intake to learn whether their state qualifies
- ✗No named 503A compounding pharmacy partner disclosed publicly — the homepage and pricing page reference '503A Pharmacy Standard' and 'licensed 503A compounding pharmacies' but do not name a specific pharmacy operator, limiting independent licensure verification
- ✗No LegitScript, PCAB, or BBB trust-signal badges visible on the homepage footer in this verification pass — a meaningful omission for a DTC compounded-GLP-1 platform launched 2026-Q1 (site Schema.org datePublished 2026-04-21)
- ✗Brand confusion risk: schema.org Organization name on the homepage is 'CatalystMD' (with a CatalystMD logo file referenced) while the customer-facing brand is 'Aquivia Health' — the parent/operating-entity relationship is not disclosed in the public footer or About page in this verification pass
- ✗Compounded semaglutide and tirzepatide are not FDA-approved and have not undergone FDA premarket review for safety, efficacy, or manufacturing quality
- ✗Site is recently launched (Schema.org datePublished 2026-04-21, dateModified 2026-05-24) with no Trustpilot, BBB, or third-party-reviews profile yet that could be independently verified
- ✗Two of the three advertised programs (Performance Longevity, Dysautonomia/POTS) are waitlist-only — only the GLP-1 Weight Loss / Metabolic Health pathway is currently 'Available Now'
Vytora Health
Pros
- ✓All 50 states + DC coverage with explicit per-state-modality compliance (video vs audio) disclosure
- ✓Both compounded AND brand-name options on a single platform — uncommon (most compounded-focused providers do not offer brand)
- ✓LegitScript Approved + HIPAA Compliant — both disclosed primary-source-verifiable
- ✓Pharmacy partners named publicly: Vials Pharmacy (TX) + Greenwich Biosciences — uncommon transparency
- ✓Owner / operating PC disclosed: Wasef Health, PC (Pinellas Park, FL)
- ✓Month-to-month pricing competitive ($180 sema / $249 tirz) and 3-month bundle (17% discount) for cost-sensitive patients
- ✓Brand-name Mounjaro and Zepbound available for patients who can self-pay $1,399/mo for FDA-approved options
- ✓Adjunct peptide offerings (NAD+, Sermorelin) for patients pursuing broader optimization regimens
Cons
- ✗Brand-name Mounjaro/Zepbound pricing ($1,399/mo) is near-retail; insured patients should pursue PA through traditional pharmacy + LillyDirect Self Pay Journey Program ($449-$699/mo) for better economics
- ✗Compounded tirzepatide tier ($249/mo) is above the lowest market floor ($149-199/mo) — Vytora pricing is mid-market for compounded
- ✗Specific dose-tier pricing not publicly broken out — pricing shown as 'all doses included' which is favorable but means high-dose patients pay the same as low-dose patients
- ✗Initial consultation cost not disclosed on public-facing pricing page (some providers free, some $99)
- ✗Limited primary-source-verifiable state licensure detail per individual prescriber (most multi-state telehealth platforms have this gap)
Our Verdict
Vytora Health edges out Aquivia Health with a higher overall score of 8.7/10 and is particularly strong for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.. Aquivia Health remains a solid alternative, especially if you're looking for Self-pay patients who want a clinician-reviewed (not algorithmic) compounded-GLP-1 pathway at the low end of the WLR compounded cluster ($149/mo semaglutide, $179/mo tirzepatide) AND want the option to upgrade to branded Ozempic/Zepbound at the same operator. Buyers who value a named clinical MSO partner (Open Loop Healthcare Partners, PC) and a co-founder team that publicly discloses credentials (MD + PharmD + operations executive). NOT ideal for buyers who require an upfront state-availability disclosure (Aquivia does not publish a state allowlist), buyers who require LegitScript/PCAB/BBB badges in the footer as a precondition (none visible in this verification pass), or buyers in coming-soon program categories (Performance Longevity, Dysautonomia/POTS are waitlist-only)..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Aquivia Health and Vytora Health head-to-heads in the same category.
- Aquivia Health vs CoreAge Rx
- Aquivia Health vs TrimRx
- Aquivia Health vs Amazon One Medical
- Vytora Health vs NovoCare Pharmacy
- Vytora Health vs Enhance MD
- Vytora Health vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.